30 results
6-K
EX-1.1
RDHL
Redhill Biopharma Ltd.
3 Apr 24
Current report (foreign)
7:00am
, judgment, order, writ, decree, privacy policy (each of which has been provided to special counsel to each Investor, as applicable) or contract to which … to the Company or the Subsidiary (including, without limitation, those related to privacy, personally identifiable information or export control), subject
F-1
EX-10.26
RDHL
Redhill Biopharma Ltd.
9 Feb 24
Registration statement (foreign)
4:20pm
, CLIA, and all Privacy Laws.
Case Report Form (“CRF"). A report in a format prepared by the Protocol Sponsor or the CRO as approved by RedHill … thereunder, including the federal privacy regulations contained in 45 CFR Parts 160 and 164 (the “Federal Privacy Regulations”), the federal security standards
6-K
EX-1.1
RDHL
Redhill Biopharma Ltd.
26 Jan 24
Current report (foreign)
9:31am
to fraud and abuse, payment transparency, and privacy and security of protected health information (collectively, “Health Care Laws”). The Company … or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection
6-K
EX-1.1
RDHL
Redhill Biopharma Ltd.
25 Jul 23
Securities Purchase Agreement
12:09pm
, state, local and foreign health care regulatory laws, including without limitation, laws related to fraud and abuse, payment transparency, and privacy … obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access
6-K
EX-1.1
znbbi57nk0soz1gtdw55
3 Apr 23
Securities Purchase Agreement
8:51am
6-K
EX-99.1
9z0v0deokf
13 Sep 22
Current report (foreign)
7:00am
6-K
EX-1.1
xc4qbx4kkrx7kre6e
11 May 22
Current report (foreign)
8:56am
424B5
dhqqr
22 Nov 21
Prospectus supplement for primary offering
4:30pm
424B5
4blc chpmbw9ijym
18 Nov 21
Prospectus supplement for primary offering
4:17pm
424B5
4w80pksv
3 Mar 21
Prospectus supplement for primary offering
4:31pm
424B5
2l2 gxyc0a1
1 Mar 21
Prospectus supplement for primary offering
4:56pm
F-3
27lgna q4dd8
24 Jul 19
Shelf registration (foreign)
7:03am